UY28861A1 - Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias - Google Patents

Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias

Info

Publication number
UY28861A1
UY28861A1 UY28861A UY28861A UY28861A1 UY 28861 A1 UY28861 A1 UY 28861A1 UY 28861 A UY28861 A UY 28861A UY 28861 A UY28861 A UY 28861A UY 28861 A1 UY28861 A1 UY 28861A1
Authority
UY
Uruguay
Prior art keywords
treatment
new pharmacological
pharmacological combinations
respiratory road
road diseases
Prior art date
Application number
UY28861A
Other languages
English (en)
Inventor
Michael P Pieper
Klaus Rudolf
Philipp Lustenberger
Thierry Bouyssou
Ingo Konetzki
Andreas Schnapp
Christoph Hoenke
Sabine Pestel
Michel Pairet
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34966478&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28861(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE102004019540A external-priority patent/DE102004019540A1/de
Priority claimed from DE102004052987A external-priority patent/DE102004052987A1/de
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of UY28861A1 publication Critical patent/UY28861A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Abstract

La presente invención se refiere a nuevas combinaciones farmacológicas que, además de uno o varios, preferentemente de un compuesto de la fórmula general 1,en la que los radicales R1, R2 y R3 pueden tener los significados mencionados en las reivindicaciones y en la descripción, contienen al menos otro principio activo 2, a procedimientos para su preparación, así como a su uso como medicamentos.
UY28861A 2004-04-22 2005-04-19 Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias UY28861A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004019540A DE102004019540A1 (de) 2004-04-22 2004-04-22 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
DE102004052987A DE102004052987A1 (de) 2004-11-03 2004-11-03 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen
EP05002496 2005-02-07

Publications (1)

Publication Number Publication Date
UY28861A1 true UY28861A1 (es) 2005-11-30

Family

ID=34966478

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28861A UY28861A1 (es) 2004-04-22 2005-04-19 Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias

Country Status (31)

Country Link
EP (2) EP2422786B1 (es)
JP (1) JP2007533683A (es)
KR (2) KR20130049840A (es)
AR (1) AR049262A1 (es)
AT (1) ATE539754T1 (es)
AU (1) AU2005235419B2 (es)
BR (1) BRPI0510080B8 (es)
CA (1) CA2559699C (es)
CY (3) CY1113890T1 (es)
DK (2) DK2422786T3 (es)
EA (1) EA013157B1 (es)
EC (1) ECSP066947A (es)
ES (2) ES2380370T3 (es)
FI (1) FIC20170005I1 (es)
HU (1) HUS1500058I1 (es)
IL (2) IL177685A (es)
LT (1) LTC1781298I2 (es)
LU (1) LU93066I2 (es)
MY (1) MY148945A (es)
NL (1) NL300779I2 (es)
NO (2) NO337714B1 (es)
NZ (1) NZ550797A (es)
PE (1) PE20060462A1 (es)
PL (2) PL1781298T4 (es)
PT (2) PT2422786E (es)
SG (1) SG152237A1 (es)
SI (2) SI2422786T1 (es)
TW (2) TWI374739B (es)
UY (1) UY28861A1 (es)
WO (1) WO2005102349A1 (es)
ZA (1) ZA200606624B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024452A1 (de) * 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation von Betaagonisten
US7923455B2 (en) * 2005-01-28 2011-04-12 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of heart failure comprising administration of an anticholinergic
EP1855689A1 (en) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising anticholinergics and etiprednol
CN101208316B (zh) 2005-08-15 2012-05-09 贝林格尔·英格海姆国际有限公司 制备β-模拟物的方法
US20070088030A1 (en) * 2005-10-10 2007-04-19 Barbara Niklaus-Humke Aerosol formulations for the inhalation of beta-agonists
US20070086957A1 (en) * 2005-10-10 2007-04-19 Thierry Bouyssou Combination of medicaments for the treatment of respiratory diseases
WO2007058971A2 (en) * 2005-11-10 2007-05-24 Bodor Nicholas S Soft anticholinergic esters
WO2007093608A1 (de) * 2006-02-16 2007-08-23 Boehringer Ingelheim International Gmbh Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
US20090324510A1 (en) 2006-08-07 2009-12-31 Boehringer Ingelheim International Gmbh Drug combinations for the treatment of respiratory tract diseases
UY30543A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) * 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
JP2010507617A (ja) * 2006-10-26 2010-03-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 呼吸器系及び消化器系障害の治療用の新規な医薬組成物
EP1921070A1 (de) 2006-11-10 2008-05-14 Boehringer Ingelheim Pharma GmbH & Co. KG Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung
AU2009211523B2 (en) 2008-02-07 2014-03-13 Boehringer Ingelheim International Gmbh Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
CA2733153C (en) 2008-08-08 2016-11-08 Boehringer Ingelheim International Gmbh Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
JP2012509922A (ja) * 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
WO2014016548A2 (en) * 2012-07-27 2014-01-30 Cipla Limited Pharmaceutical composition
EP2906218B1 (en) 2012-10-09 2016-12-14 Boehringer Ingelheim International GmbH Beta-2-adrenoceptor agonist for the treatment of cough

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4460581A (en) * 1982-10-12 1984-07-17 Boehringer Ingelheim Kg (1-Hydroxy-2-amino-alkyl)-substituted benzoxazinones and benzoxazolinones
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
EP1305300A1 (de) 2000-04-27 2003-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Neue, langwirksame betamimetika, verfahren zu deren herstellung und deren verwendung als arzneimittel
HU226830B1 (en) 2000-10-12 2009-11-30 Boehringer Ingelheim Pharma Thiotropium bromide monohydrate, method for producing the same and a pharmaceutical composition containing the same
DK1401445T3 (da) 2001-06-22 2006-11-27 Boehringer Ingelheim Pharma Krystallinsk anticholinergikum, fremgangsmåde til fremstilling af dette og anvendelse af dette til fremstilling af et lægemiddel
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2203327B1 (es) * 2002-06-21 2005-06-16 Almirall Prodesfarma, S.A. Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen.
DE10230751A1 (de) * 2002-07-09 2004-01-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung

Also Published As

Publication number Publication date
CY1113890T1 (el) 2016-07-27
AU2005235419B2 (en) 2010-11-04
SG152237A1 (en) 2009-05-29
SI1781298T1 (sl) 2012-04-30
PL1781298T4 (pl) 2017-07-31
ECSP066947A (es) 2007-01-26
LU93066I2 (fr) 2016-07-11
ES2380370T3 (es) 2012-05-11
NL300779I2 (nl) 2017-11-02
JP2007533683A (ja) 2007-11-22
IL177685A (en) 2013-10-31
BRPI0510080A (pt) 2007-10-16
CY1115719T1 (el) 2017-01-25
NO337714B1 (no) 2016-06-06
FIC20170005I1 (fi) 2017-01-13
NO2016022I1 (no) 2016-12-01
IL226562A0 (en) 2013-06-27
TWI374739B (en) 2012-10-21
ATE539754T1 (de) 2012-01-15
EP2422786A1 (de) 2012-02-29
PT1781298E (pt) 2012-02-03
CY2017014I2 (el) 2017-11-14
ES2523518T3 (es) 2014-11-26
NO2016022I2 (no) 2016-12-01
PE20060462A1 (es) 2006-06-19
CA2559699C (en) 2012-06-19
TW201231055A (en) 2012-08-01
KR101287460B1 (ko) 2013-07-23
PL2422786T3 (pl) 2015-02-27
PT2422786E (pt) 2014-11-12
CA2559699A1 (en) 2005-11-03
EP2422786B1 (de) 2014-08-13
HUS1500058I1 (hu) 2016-01-28
BRPI0510080B1 (pt) 2020-08-18
NZ550797A (en) 2010-08-27
IL177685A0 (en) 2006-12-31
KR20130049840A (ko) 2013-05-14
KR20070015592A (ko) 2007-02-05
TWI372056B (en) 2012-09-11
PL1781298T3 (pl) 2012-06-29
WO2005102349A1 (de) 2005-11-03
EA013157B1 (ru) 2010-02-26
EP1781298B1 (de) 2012-01-04
NO20065060L (no) 2006-11-21
EA200601846A1 (ru) 2007-04-27
AU2005235419A1 (en) 2005-11-03
DK1781298T3 (da) 2012-05-07
BRPI0510080B8 (pt) 2021-05-25
MY148945A (en) 2013-06-14
DK2422786T3 (da) 2014-11-17
CY2017014I1 (el) 2017-11-14
LTC1781298I2 (lt) 2018-09-25
ZA200606624B (en) 2008-01-08
AR049262A1 (es) 2006-07-12
SI2422786T1 (sl) 2014-12-31
EP1781298A1 (de) 2007-05-09

Similar Documents

Publication Publication Date Title
UY28861A1 (es) Nuevas combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
AR057148A1 (es) Combinaciones farmacologicas para el tratamiento de enfermedades de las vias respiratorias
ECSP077331A (es) Nuevos betamiméticos para el tratamiento de enfermedades de vías respiratorias
DOP2006000169A (es) Inhibidores espiropiperidina de beta-secretasa para el tratamiento de la enfermedad de alzheimer
UY29963A1 (es) Compuestos terapéuticos: piridinas y pirazinas como andamios
ECSP055774A (es) Nuevo medicamento para el tratamiento de la enfermedad pulmonar obstructiva crónica
ECSP066948A (es) Benzoxazinas para el tratamiento de enfermedades de las vías respiratorias
UY28936A1 (es) Grupo de compuestos benzoil-amino-heterociclilo y composiciones farmaceuticas que los comprenden, utiles para tratamiento de enfermedades mediadas por glucoquinasa (gq)
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
CR8744A (es) Compuestos terapeuticos
AR047529A1 (es) Compuestos de quinolina sustituidos
ECSP109903A (es) Derivados de pirazinona y su uso en el tratamiento de enfermedades pulmonares
CO6491058A2 (es) Derivados de oxazina y su uso como inhibidores de bace para el tratamiento de trastornos neurológicos
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
ECSP066770A (es) Nuevos ésteres de quinuclidina cuaternizados
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
GT200500281A (es) Compuestos organicos.
ECSP088593A (es) 5-(arilsulfonil)-pirazolopiperidinas
AR054347A1 (es) Combinaciones terapeuticas para el tratamiento o la prevencion de la depresion
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
DOP2015000169A (es) Compuestos tetracíclicos sustituidos con heterociclo y usos de los mismos para el tratamiento de enfermedades víricas
AR071120A1 (es) Derivados de diosmetina, su procedimiento de preparacion, las composiciones farmaceuticas que los contienen y su uso en el tratamiento de las enfermedades venosas cronicas.
SE0401342D0 (sv) Therapeutic compounds
CO6321241A2 (es) Derivados de 1,3,4- tiadiazol espiro condensados para la inhibicion de la actividad de quinesina (ksp)

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20180322